MacroGenics | MGNX - Eigenkapital Und Reserven

Aktienkurs
3.01
Täglich Wechseln
-0.04 -1.31%
Monatlich
9.06%
Jährlich
88.13%
Q2 Prognose
3.12




Eigenkapital Und Reserven Veränderung Datum
AbbVie USD -3.27B 628M 2025-12
Amgen USD 8.66B 961M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Daiichi Sankyo JPY 1.71T 57.86B 2025-12
Eli Lilly USD 26.54B 2.74B 2025-12
Genmab DKK 5.85B 96M 2025-12
Geron USD 225.87M 22.83M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
J&J USD 81.19B 358M 2026-03
Karyopharm Therapeutics USD -292.93M 23.67M 2025-12
MacroGenics USD 55.59M 11.41M 2025-12
Merck USD 51.85B 2.79B 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.26B 299.1M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Xencor USD 635.59M 10.27M 2025-12